Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicare Rx Impact On Overall Cost To Be Measured By Maine, Mine Workers

Executive Summary

A Health Care Financing Administration demonstration project with the United Mine Workers of America Health and Retirement Funds will examine the impact of a Medicare Rx benefit on overall health spending.

You may also be interested in...



Maine Medicaid Waiver Qualifies For Rx Rebates By State Contributions – Court

Maine's Medicaid waiver program qualifies for manufacturer rebates because of the state's contribution to beneficiaries' prescription costs, the D.C. federal court decided Feb. 25

Maine Medicaid Waiver Qualifies For Rx Rebates By State Contributions – Court

Maine's Medicaid waiver program qualifies for manufacturer rebates because of the state's contribution to beneficiaries' prescription costs, the D.C. federal court decided Feb. 25

PhRMA v. HHS

HHS lacks authority to approve Vermont Pharmacy Discount Program demonstration project extending Medicaid drug rebate structure to 70,000 beneficiaries without drug coverage, D.C. federal appeals court rules June 8. The opinion reverses Jan. 18 D.C. federal court decision denying the Pharmaceutical Research & Manufacturers of America's request for a preliminary injunction against the program (1"The Pink Sheet" Jan. 29, p. 7). "Because Congress imposed the rebate requirement in order to reduce the cost of the Medicaid program, and because no Medicaid funds are expended under the Vermont demonstration project and thus no Medicaid savings produced by the required rebates, we conclude that the department lacked the authority to approve the project," the appeals court says

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS037256

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel